Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MeiraGTx Holdings plc(MGTX) | 12,197,737 | 12,197,737 | 0 | $74.28M | $82.70M | 49.84% | +$8.42M |
| Novavax, Inc.(NVAX) | 6,880,481 | 6,880,481 | 0 | $55.32M | $44.10M | 26.58% | -$11.22M |
| Inhibrx Biosciences, Inc.(INBX) | 1,157,926 | 1,157,926 | 0 | $17.83M | $16.20M | 9.76% | -$1.63M |
| AnaptysBio | 821,917 | 821,917 | 0 | $10.88M | $15.28M | 9.21% | +$4.40M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 814,980 | 814,980 | 0 | $3.36M | $2.76M | 1.66% | -$594.9K |
| LAVA Therapeutics N.V.SHS | 1,919,455 | 1,919,455 | 0 | $1.83M | $2.44M | 1.47% | +$612.3K |
| IGM Biosciences | 1,438,975 | 1,438,975 | 0 | $8.79M | $1.65M | 1.00% | -$7.14M |
| Inozyme, Inc | 443,255 | 443,255 | 0 | $1.23M | $403.4K | 0.24% | -$824.5K |
| Q32 Bio Inc.(QTTB) | 244,083 | 244,083 | 0 | $839.6K | $402.7K | 0.24% | -$436.9K |